摘要
As a cytokine in interleukin-1(IL-1) family, interleukin-33(IL-33) usually exists in the cytoplasm and cell nucleus. When the cells are activated or damaged, IL-33 can be secreted into extracellular and regulate the functions of various immune cells through binding to its specific receptor suppression of tumorigenicity 2 (ST2). Except regulating the function of immune cells including T cells, B cells, dendritic cells (DCs),macrophages, mast cells, and innate lymphoid cells, IL-33 also plays an important role in metabolic diseases and has received an increasing attention. This review summarizes the regulation of IL-33 on different immune cells in lipid metabolism, which will help to understand the pathology of abnormal lipid metabolic diseases, such as atherosclerosis and type 2 diabetes.
| 源语言 | 英语 |
|---|---|
| 期刊论文编号 | 26 |
| 页数 | 5 |
| 期刊 | FRONTIERS IN ENDOCRINOLOGY |
| 卷 | 10 |
| DOI | |
| 出版状态 | 已出版 - 30 1月 2019 |
基金资助
This work was supported by the National Natural Science Foundation of China 81700490 to LT.
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
-
可持续发展目标 3 良好健康与福祉
关键词
- IL-33
- metabolism
- diabetes
- innate & adaptive immune response
- ST2
收录
- SCIE
学术指纹
探究 'IL-33 at the Crossroads of Metabolic Disorders and Immunity' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver